1,064 search results for “optimize drug design” in the Staff website
-
Wisse van OsFaculty of Science
w.van.os@lacdr.leidenuniv.nl | 071 5272727
-
Jannik RouselFaculty of Science
j.rousel@lacdr.leidenuniv.nl | 071 5272727
-
Rawi RamautarFaculty of Science
r.ramautar@lacdr.leidenuniv.nl | 071 5274509
-
Faisa GuledFaculty of Science
f.guled@lacdr.leidenuniv.nl | 071 5272463
-
Rongfang LiuFaculty of Science
r.liu@lacdr.leidenuniv.nl | 071 5274607
-
Douwe BreimerFaculty of Science
ddbreimer@lacdr.leidenuniv.nl | 0629046596
-
Divakar BuddaFaculty of Science
d.budda@lacdr.leidenuniv.nl | 071 5276211
-
Fouzia Lghoul-Oulad SaidFaculty of Science
f.lghoul@lacdr.leidenuniv.nl | 071 5276582
-
Anne van RongenFaculty of Science
a.van.rongen@lacdr.leidenuniv.nl | 071 5272727
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
Che XiaoFaculty of Science
c.xiao@cml.leidenuniv.nl | 071 5272727
-
Parto MirzaeiFaculty of Governance and Global Affairs
p.mirzaei@fgga.leidenuniv.nl | 070 8009506
-
Thomas ArblasterFaculty of Science
t.p.s.arblaster@cml.leidenuniv.nl | 071 5272727
-
Amer JaganjacICLON
a.jaganjac@iclon.leidenuniv.nl | 071 5272727
-
Eveline de BoerICLON
e.de.boer@iclon.leidenuniv.nl | 071 5271748
-
Dineke TigelaarICLON
dtigelaar@iclon.leidenuniv.nl | 071 5276552
-
Aparajita DuttaFaculty of Humanities
a.dutta@hum.leidenuniv.nl | 070 8002727
-
Lysanne PostICLON
l.s.post@iclon.leidenuniv.nl | 071 5272727
-
Design and Synthesis of Inhibitors and Probes for Sulfoquinovosidases and Xylanases
PhD defence
-
Design and Synthesis of Click Lipids as Tools to Study Immune Cell Metabolism
PhD defence
-
Design of branched swainsonines as selective Golgi alpha-mannosidase inhibitors
PhD defence
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
-
Master student Nicole ter Laak wins third “Dr. Saal van Zwanenberg research price”
Nicole ter Laak (Master student Biopharmaceutical sciences) has won the third price of the “Dr Saal van Zwanenberg research price”. The award ceremony is on 14 November.
-
Selective cannabinoid CB2 receptor activation in Nature Communications
This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…
-
Powerful new Leiden 'super antibiotic' may overcome resistance
The prestigious journal Science Translational Medicine has published a study by researchers from the Institute of Biology Leiden (IBL) on a potent new antibiotic that can overcome resistance. ‘The idea was to tweak the original antibiotic and create a next-generation drug’, says Nathaniel Martin, professor…
-
More contact with colleagues, no picture frames but on the wall: evaluation of activity-based working at FSW
No fixed offices, only flexible workstations: For colleagues in the Faculty Office and CADS, it has been everyday reality since the Activity-based Housing pilot. In a new evaluation, colleagues are positive, although some miss the convenience of having their own office.
-
Zware metalen hebben slechte reputatie, maar genezen ook kanker
Veel mensen denken dat zware metalen giftig zijn en mens en natuur altijd schade aanbrengen. Dat beeld moet genuanceerd worden, vindt hoogleraar Sylvestre Bonnet.
-
From lab to startup: scientist develops new treatment for nerve pain
What do you do when a discovery in the lab shows real promise? Scientist Mirjam Huizenga founded a startup to develop a new treatment for nerve pain caused by chemotherapy. ‘The goal is to give patients a better option.’
-
Referral options
If you’re unsure where to refer students to for well-being support, this page should help. It provides an overview of the support available at Leiden University.
- News
-
More research on side effects: ‘Side effects are not a side issue’
We need to be quicker and better at discovering side effects. In her inaugural lecture, Agnes Kant, Professor by Special Appointment of Innovation of Pharmacovigilance, calls for more research on these adverse effects.
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
Pharma-NL application submitted to National Growth Fund
The Ministry of Health, Welfare and Sport (VWS) submitted Pharma-NL to the R&D program of the National Growth Fund, a 20 billion euro program of the Dutch government that intends to create long-term economic growth in The Netherlands.
-
Funding for four Leiden studies in the fight against arthritis
Four researchers from Leiden University will receive funding from arthritis foundation ReumaNederland over the next five years. This should facilitate long-term research into arthritis.
-
AI Lab launched for effective and responsible supervision
How can you increase the effectiveness of inspectors using responsible artificial intelligence (AI)? This is the question the Innovation Center for Artificial Intelligence (ICAI) Lab AI4Oversight is tackling. By developing algorithms and methods, they try to provide optimal support for, for example,…
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
Sebastian Pomplun receives ERC Proof of Concept grant for MYSTIC, to advance an innovative cancer treatment idea
Sebastian Pomplun from the Leiden Academic Centre for Drug Research has recently received an ERC Proof of Concept grant for his ambitious MYSTIC project. This initiative is set to transform cancer treatment by advancing the development of HeloMYC, a pioneering therapeutic candidate designed to target…
-
Fighting gliobastoma brain tumours with two grants
Few researchers see potential in research on glioblastoma, an incurable brain tumour. Alexander Kros brought together colleagues who are up to the challenge. European research funder ERC recently made 10.6 million euros available, a year earlier NWO provided 3 million euros. ‘In six years, we certainly…
-
NWO and the National Science Foundation China award 1.1M euro to urban resilience research
Arnold Tukker and Mingming Hu (CML) will look for urban resilience solutions in the Dutch-Chinese ReSURE2 project that received 1.1M euro.
-
No higher risk of miscarriage after COVID-19
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
-
Joke Bouwstra is the first woman to receive the Dr Saal van Zwanenberg Honorary Prize: 'Wonderful to be in a line of distinguished scientists'
Emeritus professor Joke Bouwstra (LACDR) will receive this year's Dr Saal van Zwanenberg Ereprijs: a tribute to her years of fundamental research on the skin and the transport of drugs through the skin. This is the first time the prize has gone to a woman.
-
Salvador Santino Regilme awarded fellowship at NIAS
Salvador Santino Regilme has been selected for a fellowship at the Netherlands Institute for Advanced Study (NIAS) in Amsterdam. From September 2022, he will spend 5 months at NIAS working on his research project titled 'The Normative Order of the Global War on Drugs'.
-
Professor and Knight: Joke Bouwstra Receives Royal Honor
A memorable farewell symposium and a royal distinction: Professor Joke Bouwstra could not have completed her career at Leiden with more pleasure. On Friday, 14 June, she received a Royal Honor from Leiden Mayor Peter van der Velden, who appointed Bouwstra as a Knight in the Order of the Dutch Lion for…
-
Tools and support
Under tools and support you will find information intended to support you in your teaching such as the FLO team, available services and support for students, various tools for teaching and assessment, rules & regulations, and inspiration.
-
Projects 2024-2025
This academic year, seven (teams of) teachers will receive a Grassroots or Grass shoots grant. Here you can read about their projects.
-
PhD track
The PhD track involves many different aspects. As well as important administrative steps that you have to take, for example, there are also introductory activities, a training programme and opportunities for research abroad.
-
Leiden University positive about coalition plans, with a few concerns
Dutch universities have responded positively to the new coalition plans. Investments in education, research and innovation will be prioritised, and the stringent cutbacks proposed by the previous cabinet will be reversed. Optimism is the order of the day in Leiden, though caution is advised.
-
Let the robot lend a hand in the pharmacy (it’s more sustainable too)
Can a robot help prepare cancer medication in a hospital pharmacy? That’s what hospital pharmacist Tjerk Geersing investigated in his PhD research. He compared manual and automated preparations in terms of quality, efficiency, and safety. He graduated on 19 March.
-
Unlocking the secrets of DNA repair: Sarah’s curiosity might lead to new cancer treatments
How do cells repair their damaged DNA—and what happens when that process is hindered and cancer arises? Sarah Moser has taken a closer look during her PhD, uncovering surprising insights that could help improve future cancer treatments.